Early indicators, early treatments, neuroprotection in multiple sclerosis
Work detail
Early diagnosis is a new challenge for the neurologist, as demonstrated by the advantages of early treatment of multiple sclerosis with interferon beta. The rationale for early treatment is extensively reviewed together with the mechanism underlying irreversible damage in MS.
Overview
Shared work-level identity and catalog context.
Contributors
People credited with this work in the active catalog.
- Open Author
O. R. Hommes
- Open Author
Otto R. Hommes
- Open Author
O.R. Hommes
- Open Author
G. Comi
Editions
Publication-specific versions linked to this work only.
- Image source: Open LibraryEI
Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis
- Image source: Open LibraryEI
Early Indicators, Early Treatment and Neuroprotection in Multiple Sclerosis (Topics in Neuroscience)
- Image source: Open LibraryEI
Early indicators, early treatment, neuroprotection in multiple sclerosis
- EIEarly Indicators Early Treatmen...O. R. Hommes, G. Comi
Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis
- EIEarly Indicators Early Treatmen...O. R. Hommes, G. Comi
Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis
- EIEarly indicators, early treatme...
Early indicators, early treatments, neuroprotection in multiple sclerosis
